Unlocking liver health: Can tackling myosteatosis spark remission in metabolic dysfunction‐associated steatotic liver disease?
G Henin, A Loumaye, L Deldicque… - Liver …, 2024 - Wiley Online Library
Myosteatosis is highly prevalent in metabolic dysfunction‐associated steatotic liver disease
(MASLD) and could reciprocally impact liver function. Decreasing muscle fat could be …
(MASLD) and could reciprocally impact liver function. Decreasing muscle fat could be …
Revisiting the beyond BMI paradigm in excess weight diagnosis and management: A call to action
M Aguas‐Ayesa, P Yárnoz‐Esquiroz… - European Journal of …, 2024 - Wiley Online Library
Adolphe Quételet, a 19th‐century Belgian sociologist and statistician, pioneered the
incorporation of statistics into social sciences. He initiated the development of anthropometry …
incorporation of statistics into social sciences. He initiated the development of anthropometry …
[PDF][PDF] Impact of Peroxisome Proliferator-Activated Receptor Agonists on Myosteatosis in the Context of Metabolic Dysfunction-Associated Steatotic Liver Disease
N Boliaki, G Henin, G Bale… - Acta Gastro-Enterologica …, 2024 - researchgate.net
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD), and more
specifically steatohepatitis may be associated with fat infiltration of skeletal muscles which is …
specifically steatohepatitis may be associated with fat infiltration of skeletal muscles which is …
[PDF][PDF] Intramyocellular lipids are associated with insulin resistance in metabolic dysfunction-associated steatotic liver disease
Intramyocellular lipids are associated with insulin resistance in metabolic dysfunction-associated
steatotic liver disease Aim C Page 1 Scan to download the poster EASL2024 Intramyocellular …
steatotic liver disease Aim C Page 1 Scan to download the poster EASL2024 Intramyocellular …